Similar articles

• Visual acuity as an outcome measure in clinical trials of retinal diseases.

  Beck RW, Maguire MG, Bressler NM, Glassman AR, Lindblad AS, Ferris FL. Beck RW, et al. Ophthalmology. 2007 Oct;114(10):1804-9. doi: 10.1016/j.ophtha.2007.06.047. Ophthalmology. 2007. PMID: 17908590
• Near and intermediate visual acuity test.

  Jones YJ, Jones JJ. Jones YJ, et al. J Cataract Refract Surg. 2008 Feb;34(2):337-8. doi: 10.1016/j.jcrs.2007.10.013. J Cataract Refract Surg. 2008. PMID: 18242466 No abstract available.
• [Contrast sensitivity].

  Catalin PM. Catalin PM. Oftalmologia. 2002;54(3):5-10. Oftalmologia. 2002. PMID: 12723188 Review. Romanian.
• Prognostic factors for visual outcome in purtscher retinopathy.

  Holak HM, Holak S. Holak HM, et al. Surv Ophthalmol. 2007 Jan-Feb;52(1):117-8; author reply 118-9. doi: 10.1016/j.survophthal.2006.10.012. Surv Ophthalmol. 2007. PMID: 17212995 No abstract available.
• The technique, validity and clinical use of the sweep VEP.

  Almoqbel F, Leat SJ, Irving E. Almoqbel F, et al. Ophthalmic Physiol Opt. 2008 Sep;28(5):393-403. doi: 10.1111/j.1475-1313.2008.00591.x. Ophthalmic Physiol Opt. 2008. PMID: 18761477 Review.